Studies have shown that RAPA, as a targeted inhibitor of the mTOR pathway, exerts anti-inflammatory and anti-tumor effects in a variety of diseases by inhibiting the activation of the mToR pathway (30, 31). This evidence concerns the gene MTOR and neoplasm.